Thomas White
Family Medicine · Cherryville, NCNPI 1568485365
Payments from drug & device makers
Across 101 payments — averaging $375.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$18K
- Amarin Pharma, Inc.$18K
- Medicure Pharma Inc.$600
- Novo Nordisk$410
- Boehringer Ingelheim$328
- Biohaven Pharmaceutical Holding Company Ltd.$119
- plus $607 from 11 others
What the payments were for
- Consulting fees$5001%
- Speaking & faculty fees$30,73081%
- Travel & lodging$2,4717%
- Food & beverage$4,10611%
- Education$970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $18,119 |
| Amarin Pharma, Inc. | 37 | $17,720 |
| Medicure Pharma Inc. | 2 | $600 |
| Novo Nordisk | 10 | $410 |
| Boehringer Ingelheim | 3 | $328 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $119 |
| Esperion Therapeutics, Inc. | 2 | $118 |
| Johnson & Johnson | 2 | $114 |
| Sanofi-aventis U.S. LLC | 1 | $108 |
| Medtronic | 2 | $89 |
| Regeneron | 1 | $79 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Ionis Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Abbott | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$17,295
- Vascepa$16,741
- ZYPITAMAG (pitavastatin)$600
- JARDIANCE$328
- NURTEC ODT$119
- DISEASE STATE$108
- INVOKANA$106
- NEXLETOL$103
- Ozempic$100
How this compares
$37,904 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 141 | $80,761 |
| EliquisApixaban | 79 | $52,935 |
| Repatha SureclickEvolocumab | 50 | $32,650 |
| OzempicSemaglutide | 32 | $29,573 |
| MounjaroTirzepatide | 18 | $17,882 |
| VemlidyTenofovir Alafenamide | 12 | $16,261 |
| TrintellixVortioxetine Hydrobromide | 33 | $15,026 |
| VascepaIcosapent Ethyl | 35 | $12,498 |
| TrulicityDulaglutide | 13 | $11,974 |
| XareltoRivaroxaban | 13 | $11,766 |
| FarxigaDapagliflozin Propanediol | 15 | $8,186 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,449 |
| Serevent DiskusSalmeterol Xinafoate | 11 | $4,580 |
| DexilantDexlansoprazole | 12 | $3,482 |
| Omega-3 Acid Ethyl Esters | 94 | $3,281 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $328 | $80,761141 claims |
| Lilly USA, LLCMounjaro, Trulicity | $13 | $29,85631 claims |
| Novo NordiskOzempic | $410 | $29,57332 claims |
| Johnson & JohnsonXarelto | $114 | $11,76613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Cherryville
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.